Day One Biopharmaceuticals has announced the appointment of Dr. Michael Vasconcelles as Head of Research & Development, bringing over 25 years of experience in oncology research and corporate ...
Roche Holding said Johannes Clevers, head of pharmaceutical research and early development, will retire from the company after three years in the role. Clevers, who was also member of the Swiss pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback